Literature DB >> 22990219

Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence.

Kenneth A Perkins1, Joshua L Karelitz, Nancy C Jao.   

Abstract

INTRODUCTION: Smoking cessation is typically verified biochemically by expired-air carbon monoxide (CO) levels below 9 ppm (i.e., ≤8 ppm), but this CO criterion may lead many who have smoked within 24hr to be misclassified as abstinent.
METHODS: Adult dependent smokers (N = 261; 124 men, 137 women) prospectively recorded each cigarette smoked and provided CO on five consecutive days during each of two short-term attempts to quit smoking. Participants were those recruited for crossover tests of the effects of placebo versus medication (nicotine patch or varenicline) on the ability to initiate 24-hr abstinence. All had either a high or low interest in permanently quitting smoking soon (within 3 months) and were randomized to the presence or absence of daily ($12) monetary reinforcement of abstinence.
RESULTS: Total accuracy of sensitivity to detect smoking (83%) plus specificity to verify abstinence (87%) was optimal at a CO criterion for abstinence below 5 ppm (≤4 ppm), compared with below 9 ppm (sensitivity of 60%, specificity of 97%). Overall CO detection of sensitivity and specificity was higher in those with high versus low quit interest, but reinforcement of abstinence made no difference.
CONCLUSIONS: Results indicate a CO criterion half that used in most clinical research may optimally validate 24-hr cessation and reduce misclassification of smokers as "abstinent."

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990219      PMCID: PMC3733388          DOI: 10.1093/ntr/nts205

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  19 in total

Review 1.  Relapse and maintenance issues for smoking cessation.

Authors:  J K Ockene; K M Emmons; R J Mermelstein; K A Perkins; D S Bonollo; C C Voorhees; J F Hollis
Journal:  Health Psychol       Date:  2000-01       Impact factor: 4.267

2.  Biochemical verification of tobacco use and cessation.

Authors: 
Journal:  Nicotine Tob Res       Date:  2002-05       Impact factor: 4.244

3.  Predicting successful 24-hr quit attempt in a smoking cessation intervention.

Authors:  Steffani R Bailey; Susan W Bryson; Joel D Killen
Journal:  Nicotine Tob Res       Date:  2011-08-10       Impact factor: 4.244

Review 4.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Authors:  M H Zweig; G Campbell
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

5.  Detecting smoking following smoking cessation treatment.

Authors:  Peter Gariti; Arthur I Alterman; Ronald Ehrman; Francis D Mulvaney; Charles P O'Brien
Journal:  Drug Alcohol Depend       Date:  2002-01-01       Impact factor: 4.492

6.  Possible reasons for elevated carbon monoxide levels in self-reported ex-smokers.

Authors:  Daniel Kotz
Journal:  Nicotine Tob Res       Date:  2012-01-17       Impact factor: 4.244

7.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

8.  Breath carbon monoxide as an indication of smoking habit.

Authors:  E T Middleton; A H Morice
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

9.  Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004.

Authors:  Neal L Benowitz; John T Bernert; Ralph S Caraballo; David B Holiday; Jiantong Wang
Journal:  Am J Epidemiol       Date:  2008-11-19       Impact factor: 4.897

10.  DSM-III-R nicotine dependence in young adults: prevalence, correlates and associated psychiatric disorders.

Authors:  N Breslau; M M Kilbey; P Andreski
Journal:  Addiction       Date:  1994-06       Impact factor: 6.526

View more
  79 in total

1.  Validation of the Avoidance and Inflexibility Scale (AIS) among treatment-seeking smokers.

Authors:  Samantha G Farris; Michael J Zvolensky; Angelo M DiBello; Norman B Schmidt
Journal:  Psychol Assess       Date:  2015-02-02

2.  Cessation from Smoking Improves Innate Host Defense and Clearance of Experimentally Inoculated Nasal Staphylococcus aureus.

Authors:  Amy L Cole; Mary Schmidt-Owens; Ashley C Beavis; Christine F Chong; Patrick M Tarwater; James Schaus; Michael G Deichen; Alexander M Cole
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Understanding quit patterns from a randomized clinical trial: Latent classes, predictors, and long-term abstinence.

Authors:  Lorra Garey; Kara Manning; Danielle E McCarthy; Matthew W Gallagher; Justin M Shepherd; Michael F Orr; Norman B Schmidt; Blaz Rodic; Michael J Zvolensky
Journal:  Addict Behav       Date:  2019-02-21       Impact factor: 3.913

4.  Neural cue reactivity during acute abstinence predicts short-term smoking relapse.

Authors:  Cheyenne Allenby; Mary Falcone; E Paul Wileyto; Wen Cao; Leah Bernardo; Rebecca L Ashare; Amy Janes; James Loughead; Caryn Lerman
Journal:  Addict Biol       Date:  2019-02-25       Impact factor: 4.280

5.  Optimal Carbon Monoxide Criteria to Confirm Smoking Status Among Postpartum Women.

Authors:  Rebecca L Emery; Michele D Levine
Journal:  Nicotine Tob Res       Date:  2015-09-18       Impact factor: 4.244

6.  Pilot Tobacco Treatment Intervention for Women in Residential Treatment for Substance Use Disorder.

Authors:  Amanda Fallin-Bennett; Janine Barnett; Letitia Ducas; Amanda T Wiggins; Andrea McCubbin; Kristin Ashford
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2018-09-28

7.  Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement.

Authors:  Rosemarie A Martin; Damaris J Rohsenow; Jennifer W Tidey
Journal:  J Subst Abuse Treat       Date:  2019-06-10

8.  Associations between distress tolerance and asthma symptoms and quality of life.

Authors:  Talya Alsaid-Habia; Alison C McLeish; Kristen M Kraemer
Journal:  J Asthma       Date:  2018-10-04       Impact factor: 2.515

9.  A Pilot Trial Examining African American and White Responses to Algorithm-Guided Smoking Cessation Medication Selection in Persons Living with HIV.

Authors:  Pamela Valera; F Joseph McClernon; Greer Burkholder; Michael J Mugavero; James Willig; Conall O'Cleirigh; Karen L Cropsey
Journal:  AIDS Behav       Date:  2017-07

10.  Distress intolerance during smoking cessation treatment.

Authors:  Samantha G Farris; Teresa M Leyro; Nicholas P Allan; Camilla S Øverup; Norman B Schmidt; Michael J Zvolensky
Journal:  Behav Res Ther       Date:  2016-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.